The most coveted presentation slot is for —data cut just weeks before the conference. Major trials (from PrEP studies to cure research) often choose IAS for their first public reveal because the audience is uniquely qualified to critique methodology. The 2021 IAS conference, for example, saw the first data on long-acting injectable cabotegravir for PrEP, which has since transformed prevention guidelines globally.
The IAS Conference covers a wide range of topics related to HIV/AIDS, including: international aids society conference
The IAS Conference will continue to be a premier event in the global HIV/AIDS response. The next conference is scheduled to take place in 2023 in Brisbane, Australia. The most coveted presentation slot is for —data